AP
NASDAQ · APLM
Apollomics, Inc.
Healthcare · Biotechnology
$23.11
Up+$0.79 (+3.42%)
Updated Aug 25, 2026, 1:35 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 22.3M
- P/E ratio
- -0.71
- Dividend yield
- 0.00%
- 52-week range
- $3.66 – $42.12
- Volume
- 1.15K
- Avg. volume
- 23.18K
Price performance
APLM price history
1M range · 20 trading sessions · Daily adjusted prices
APLM closed at $23.11 after 20 trading sessions, up 28.37% for the selected period.
- Last close
- $23.11
- Period change
- +28.37%
- Period low
- $16.90
- Period high
- $24.33
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | $24.9999 | $24.9999 | $22.8001 | $23.1068 | 1.15K |
| Aug 21, 2026 | $22.93 | $24.59 | $22.93 | $24.3268 | 6.29K |
| Aug 20, 2026 | $24.27 | $24.4348 | $22.79 | $23.57 | 5.6K |
| Aug 19, 2026 | $23.92 | $24.00 | $21.00 | $23.59 | 7.94K |
| Aug 18, 2026 | $25.41 | $27.16 | $23.60 | $23.92 | 18.29K |
| Aug 17, 2026 | $22.96 | $25.50 | $22.3305 | $23.55 | 35.55K |
| Aug 14, 2026 | $17.74 | $24.00 | $17.275 | $23.40 | 47.75K |
| Aug 13, 2026 | $17.20 | $17.4118 | $17.10 | $17.37 | 6.19K |
| Aug 12, 2026 | $18.36 | $18.36 | $16.70 | $17.06 | 11.33K |
| Aug 11, 2026 | $18.13 | $18.20 | $18.13 | $18.16 | 1.77K |
| Aug 10, 2026 | $17.32 | $17.85 | $17.2656 | $17.85 | 4.35K |
| Aug 7, 2026 | $17.27 | $17.27 | $16.90 | $16.90 | 7.42K |
| Aug 6, 2026 | $17.00 | $17.00 | $17.00 | $17.00 | 1.28K |
| Aug 5, 2026 | $17.75 | $19.00 | $17.25 | $17.28 | 419.49K |
| Aug 4, 2026 | $17.88 | $17.88 | $17.40 | $17.575 | 4.08K |
| Jul 31, 2026 | $17.10 | $17.245 | $16.90 | $17.245 | 5.28K |
| Jul 30, 2026 | $17.20 | $17.80 | $17.10 | $17.35 | 3.56K |
| Jul 29, 2026 | $18.05 | $18.20 | $17.40 | $17.48 | 9.14K |
| Jul 28, 2026 | $18.03 | $18.48 | $18.00 | $18.22 | 5.81K |
| Jul 27, 2026 | $18.072 | $18.7551 | $18.00 | $18.00 | 12.14K |
Latest APLM news
The latest Smart Investors Daily articles mentioning APLM.
Stock researchResearch & News · Competitors
Loading stock research…
